Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
In Esports, Gaming and Gamers Join the Big Leagues

Oct 1, 2020/Feature

PTs are making their mark in what has become a billion-dollar industry.

Use of Artificial and Augmented Technology in Physical Therapy Task Force

Aug 1, 2025/Open Access

The Use of Artificial and Augmented Technology in Physical Therapy Task Force is appointed by the APTA Board of Directors. The detailed charge outlining the roles and responsibilities of this committee is provided below.

Advocacy Issues

APTA shapes policy issues that impact our profession and the patients and clients we serve.

APTA State Legislative Update: Direct Access, Compact, Payment, and More

Apr 6, 2023/Podcast

Join APTA staff experts for a quick look at what's happening in statehouses this legislative season.

Twelve Months of Health Care Awareness

May 1, 2020/Feature

Beyond National Physical Therapy Month in October, how many months, weeks, and days do you know that have been designated to highlight conditions that PTs and PTAs manage? There probably are more than you think!

Bills To Expand Telehealth to PTs and PTAs Now in Both Senate and House

Nov 15, 2021/News

The Senate version of the Expanded Telehealth Access Act is helping to build momentum for change.

McMillan, Maley Lectures to Feature Thought Leaders in VR, Orthopaedic Research

Aug 30, 2023/News

Judith Deutsch is the 2024 McMillan Lecturer; Philip McClure will deliver the 29th Maley Lecture.

PTJ Author Interview With John Ware and Thomas Hoogeboom: Recognizing Conflict of Interest and Researcher Allegiance

Sep 12, 2023/Podcast

How better reporting can lead to improved credibility.

Blunt Conversations: Setting Realistic Patient Expectations for Pain

Apr 22, 2018/Interview

Clinicians need to give patients realistic expectations for pain and pain relief. But how?

Physical Therapy and Occupational Therapy Provide Significant Rehabilitative Value in Postacute Care

Apr 5, 2021/Statement

Study across 1.4 million Medicare cases indicates patients receiving these therapies have better quality of life and fewer hospital readmissions.